日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The miRNA-immune axis in bladder cancer: systematic evidence for a new era of immunotherapy precision

膀胱癌中的miRNA-免疫轴：免疫治疗精准治疗新时代的系统性证据

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1639334
Dulf, Daniel-Vasile; Ravegnini, Gloria; Giorgi, Federico Manuel; Burnar, Anamaria Larisa; Gorini, Francesca; De Leo, Antonio; Luţichievici, Harisa; Opriţa, Constantin-Lucian; Todiruţ, Cezar-Nicolae; Ciuleanu, Tudor-Eliade; Coadă, Camelia Alexandra
肿瘤
肿瘤免疫
miRNA
膀胱癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Prospective Upfront Next-Generation Sequencing for Advanced Non-Small Cell Lung Cancer: Real-World Outcomes from the Ion Chiricuță Oncology Institute

前瞻性二代测序治疗晚期非小细胞肺癌：来自伊恩·奇里库塔肿瘤研究所的真实世界结果

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26073403
Preda, Alexandra Cristina; Todor, Nicolae; Cârlan, Bogdan; Kubelac-Varro, Adelina-Dadiana; Iancu, Dana Ioana; Mocan, Cristina; Vasilica, Mariana Bandi; Kubelac, Milan-Paul; Vlad, Cătălin; Ciuleanu, Tudor Eliade
细胞生物学
肿瘤
肿瘤免疫
肺癌
发表日期：2025
文献求助 收藏

The Genomic Landscape of Romanian Non-Small Cell Lung Cancer Patients: The Insights from Routine NGS Testing with the Oncomine Dx Target Panel at the PATHOS Molecular Pathology Laboratory

罗马尼亚非小细胞肺癌患者的基因组图谱：PATHOS分子病理实验室使用Oncomine Dx Target Panel进行常规NGS检测的启示

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17121947
Gaal, Orsolya I; Ungureanu, Andrei; Pop, Bogdan; Tomescu, Andreea; Cătană, Andreea; Man, Milena; Râjnoveanu, Ruxandra Mioara; Palade, Emanuel; Simon, Marioara; Luchian, Stefan Dan; Kubelac, Milan Paul; Fulop, Annamaria; Fekete, Zsolt; Ciuleanu, Tudor Eliade; Jentimir, Ion; Popovici, Bogdan; Cainap, Calin; Preda, Alexandra Cristina; Magdau, Cosmina; Lesan, Andrei; Fetica, Bogdan
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Chemo-Radio-Immunotherapy Strategies to Prevent Immune Resistance in Non-Small Cell Lung Cancer

化疗-放疗-免疫疗法策略预防非小细胞肺癌的免疫耐药性

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18010137
Rusu-Patraulea, Renata-Andrea; Rusu, Petronela; Ciuleanu, Tudor-Eliade
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center

抗PD-1治疗下非小细胞肺癌和黑色素瘤患者血清TNF-α、IL-10和IL-2水平变化轨迹及预后：来自单中心的纵向真实世界证据

期刊:Current Issues in Molecular Biology
影响因子:3
doi:10.3390/cimb47090746
Grecea-Balaj, Alina Miruna; Soritau, Olga; Brie, Ioana; Perde-Schrepler, Maria; Virag, Piroska; Fischer-Fodor, Eva; Todor, Nicolae; Cenariu, Mihai; Nedelea, Ioana; Ciuleanu, Tudor Eliade
黑色素瘤
肺癌
肿瘤
肿瘤免疫
IL-10
TNF-α
IL-2
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Lymphovascular Invasion Is a Predictor of Clinical Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy

淋巴血管侵犯是接受根治性膀胱切除术治疗的膀胱癌患者临床结局的预测因子

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14145120
Dulf, Daniel-Vasile; Burnar, Anamaria Larisa; Dulf, Patricia-Lorena; Matei, Doina-Ramona; Hendea, Raluca Maria; Andraș, Iulia; Grecea, Miruna; Bungărdean, Cătălina; De Leo, Antonio; Ciuleanu, Tudor-Eliade; Crișan, Nicolae; Coada, Camelia Alexandra
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Risk Stratification Using a Perioperative Nomogram for Predicting the Mortality of Bladder Cancer Patients Undergoing Radical Cystectomy

利用围手术期列线图进行风险分层，预测接受根治性膀胱切除术的膀胱癌患者的死亡率

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14165810
Dulf, Daniel-Vasile; Burnar, Anamaria Larisa; Dulf, Patricia-Lorena; Matei, Doina-Ramona; Maria, Hendea Raluca; Bungărdean, Cătălina; Buzoianu, Maximilian; Andraș, Iulia; Ciuleanu, Tudor-Eliade; Crișan, Nicolae; Coadă, Camelia Alexandra
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial

CheckMate 9LA随机试验中，一线纳武利尤单抗联合伊匹木单抗和化疗治疗转移性非小细胞肺癌的四年临床更新和治疗转换调整后的结果

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008189
Carbone, David P; Ciuleanu, Tudor-Eliade; Schenker, Michael; Cobo, Manuel; Bordenave, Stéphanie; Juan-Vidal, Oscar; Menezes, Juliana; Reinmuth, Niels; Richardet, Eduardo; Cheng, Ying; Mizutani, Hideaki; Felip, Enriqueta; Zurawski, Bogdan; Alexandru, Aurelia; Paz-Ares, Luis; Lu, Shun; John, Thomas; Zhang, Xiaoqing; Mahmood, Javed; Hu, Nan; De, Tuli; Santi, Irene; Penrod, John R; Yuan, Yong; Lee, Adam; Reck, Martin
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

一项随机、开放标签的 II 期研究，旨在评估纳武利尤单抗联合伊匹木单抗或纳武利尤单抗单药治疗高肿瘤突变负荷的晚期或转移性实体瘤患者的疗效。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-008872
Schenker, Michael; Burotto, Mauricio; Richardet, Martin; Ciuleanu, Tudor-Eliade; Gonçalves, Anthony; Steeghs, Neeltje; Schoffski, Patrick; Ascierto, Paolo A; Maio, Michele; Lugowska, Iwona; Lupinacci, Lorena; Leary, Alexandra; Delord, Jean-Pierre; Grasselli, Julieta; Tan, David S P; Friedmann, Jennifer; Vuky, Jacqueline; Tschaika, Marina; Konduru, Somasekhar; Vemula, Sai Vikram; Slepetis, Ruta; Kollia, Georgia; Pacius, Misena; Duong, Quyen; Huang, Ning; Doshi, Parul; Baden, Jonathan; Di Nicola, Massimo
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment-The Experience of Ion Chiricuță Oncology Institute

一线治疗晚期非小细胞肺癌中不同抗PD-1检查点联合策略的应用——Ion Chiricuță肿瘤研究所的经验

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16112022
Preda, Alexandra-Cristina; Ciuleanu, Tudor-Eliade; Todor, Nicolae; Vlad, Cătălin; Iancu, Dana Ioana; Mocan, Cristina; Bandi-Vasilica, Mariana; Albu, Florina; Todor-Bondei, Irina Mihaela; Hapca, Mădălina Claudia; Kubelac, Milan-Paul; Kubelac-Varro, Adelina Dadiana
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
PD-1
发表日期：2024
文献求助 收藏